PDF herunterladen
CC BY-NC-ND 4.0 · Eur J Dent 2020; 14(04): 665-671
DOI: 10.1055/s-0040-1716443
Review Article

Salivary IgA as a Useful Biomarker for Dental Caries in Down Syndrome Patients: A Systematic Review and Meta-analysis

Hiba Hamid 
1   Department of Oral Biology, Liaquat College of Medicine & Dentistry, Karachi, Pakistan
,
Necdet Adanir 
2   Department of Restorative Dentistry, College of Dentistry, King Faisal University, Al Ahsa, Saudi Arabia
,
Faris Yahya Ibrahim Asiri
3   Department of Preventive Dentistry, College of Dentistry, King Faisal University, Al Ahsa, Saudi Arabia
,
Khadijah Abid
4   Department of Biostatistic, College of Physicians and Surgeons Pakistan, Karachi, Pakistan
,
Muhammad Sohail Zafar 
5   Department of Restorative Dentistry, College of Dentistry, Taibah University, Medina, Saudi Arabia
6   Department of Dental Materials, Islamic International Dental College, Riphah International University, Islamabad, Pakistan
,
Zohaib Khurshid
7   Department of Prosthodontics and Dental Implantology, College of Dentistry, King Faisal University, Al Ahsa, Saudi Arabia
› Institutsangaben Funding None.
› Weitere Informationen
   Lizenzen und Reprints

Abstract

The objective of this systematic review and meta-analysis is to critically analyze and summarize studies reporting association of salivary immunoglobulin A (IgA) levels as a biomarker for dental caries in Down syndrome (DS) patients. Using the keywords salivary [All Fields] AND IgA [All Fields] AND (“down syndrome” [MeSH Terms] OR (“down”[All Fields] AND “syndrome” [All Fields]) OR “down syndrome” [All Fields]), an electronic search was conducted via PubMed and Scopus databases by two authors, H. H. and Z. K. independently. Retrieved studies were screened against the predefined exclusion and inclusion criteria. To estimate the risk of bias, quality assessment of included studies was carried using the Newcastle–Ottawa quality assessment scale for observational studies. Primary search resulted in 10 articles from PubMed and 13 articles from Scopus. Ten studies fulfilled the defined selection criteria and evaluated the salivary IgA (sIgA) level in DS patients with dental caries. Five articles were further analyzed in a quantitative synthesis presented in the meta-analysis. Due to a modified lifestyle and compromised oral hygiene in DS patients, understandably, it is still postulated in the literature that the presence of sIgA can have a protective effect on the occurrence of dental caries as compared with healthy counterparts. As indicated by the present meta-analysis, no conclusions can be drawn as to definitively label sIgA as a biomarker for dental caries. Further, well-designed longitudinal clinical studies and translational research are therefore required before the benchmarking of sIgA as a useful biomarker for dental caries in DS patients with preferable molecular insights.

Keywords

saliva - dental caries - salivary IgA - Down syndrome


Publikationsverlauf

Artikel online veröffentlicht:
24. September 2020

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Human Genomics in Global Health. Genes and human diseases Available at: https://www.who.int/genomics/public/geneticdiseases/en/index1.html. Accessed November 17, 2019
  • 2 Cogulu D, Sabah E, Kutukculer N, Ozkinay F. Evaluation of the relationship between caries indices and salivary secretory IgA, salivary pH, buffering capacity and flow rate in children with Down’s syndrome. Arch Oral Biol 2006; 51 (01) 23-28
    CrossrefPubMedGoogle Scholar
  • 3 Areias C, Sampaio-Maia B, Pereira MdeL. et al. Reduced salivary flow and colonization by mutans streptococci in children with Down syndrome. Clinics (São Paulo) 2012; 67 (09) 1007-1011
    CrossrefPubMedGoogle Scholar
  • 4 Cornejo LS, Zak GA, de Cattoni STD, Calamari SE, Azcurra AI, Battellino LJ. Bucodental health condition in patients with Down syndrome of Cordoba City, Argentina. Acta Odontol Latinoam 1996; 9 (02) 65-79
    PubMedGoogle Scholar
  • 5 Soham B, Srilatha KT, Seema D. Salivary characteristics of Down’s syndrome children- a review. J Oral Hyg Heal 2016; 4: 201
    Google Scholar
  • 6 Normastura A, Norhayani Z, Azizah Y, Malaysiana MK-S. Saliva and dental caries in Down syndrome children. Sains Malaysiana 2013; 42 (01) 59-63
    Google Scholar
  • 7 Castilho ARF, Pardi V, Pereira CV. Caries prevalence, level of mutans streptococci, salivary flow rate, and buffering capacity in subjects with Down syndrome. Braz J Oral Sci 2007; 6 (21) 1331-1336
    Google Scholar
  • 8 Hashizume LN, Schwertner C, Moreira MJS, Coitinho AS, Faccini LS. Salivary secretory IgA concentration and dental caries in children with Down syndrome. Spec Care Dentist 2017; 37 (03) 115-119
    CrossrefPubMedGoogle Scholar
  • 9 Morinushi T, Lopatin DE, Van Poperin N. The relationship between gingivitis and the serum antibodies to the microbiota associated with periodontal disease in children with Down’s syndrome. J Periodontol 1997; 68 (07) 626-631
    CrossrefPubMedGoogle Scholar
  • 10 Lee SR, Kwon HK, Song KB, Choi YH. Dental caries and salivary immunoglobulin A in Down syndrome children. J Paediatr Child Health 2004; 40 (9-10) 530-533
    CrossrefPubMedGoogle Scholar
  • 11 Baliga S, Muglikar S, Kale R. Salivary pH: a diagnostic biomarker. J Indian Soc Periodontol 2013; 17 (04) 461-465
    CrossrefPubMedGoogle Scholar
  • 12 Khurshid Z, Naseem M, Sheikh Z, Najeeb S, Shahab S, Zafar MS. Oral antimicrobial peptides: types and role in the oral cavity. Saudi Pharm J 2016; 24 (05) 515-524
    CrossrefPubMedGoogle Scholar
  • 13 Khurshid Z, Zafar MS, Khan RS, Najeeb S, Slowey PD, Rehman IU. Role of salivary biomarkers in oral cancer detection. Adv Clin Chem 2018; 86: 23-70
    CrossrefPubMedGoogle Scholar
  • 14 Shazam H, Shaikh F, Hussain Z, Majeed MM, Khan S, Khurshid Z. Evaluation of osteocalcin levels in saliva of periodontitis patients and their correlation with the disease severity: a cross-sectional study. Eur J Dent 2020; 14 (03) 352-359
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 15 Hamid H, Khurshid Z, Adanir N, Zafar MS, Zohaib S. COVID-19 pandemic and role of human saliva as a testing biofluid in point-of-care technology. Eur J Dent 2020; DOI: 10.1055/s-0040-1713020.
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 16 Khurshid Z, Zafar M, Khan E, Mali M, Latif M. Human saliva can be a diagnostic tool for Zika virus detection. J Infect Public Health 2019; 12 (05) 601-604
    CrossrefPubMedGoogle Scholar
  • 17 Ranadheer E, Nayak UA, Reddy NV, Rao VA. The relationship between salivary IgA levels and dental caries in children. J Indian Soc Pedod Prev Dent 2011; 29 (02) 106-112
    CrossrefPubMedGoogle Scholar
  • 18 Katz J, Harmon CC, Buckner GP, Richardson GJ, Russell MW, Michalek SM. Protective salivary immunoglobulin A responses against Streptococcus mutans infection after intranasal immunization with S. mutans antigen I/II coupled to the B subunit of cholera toxin. Infect Immun 1993; 61 (05) 1964-1971
    CrossrefPubMedGoogle Scholar
  • 19 Fontana M, Gfell LE, Gregory RL. Characterization of preparations enriched for Streptococcus mutans . Clin Diagn Lab Immunol 1995; 2 (06) 719-725
    CrossrefPubMedGoogle Scholar
  • 20 Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339: b2535
    CrossrefPubMedGoogle Scholar
  • 21 Chaushu S, Yefe Nof E, Becker A, Shapira J, Chaushu G. Parotid salivary immunoglobulins, recurrent respiratory tract infections and gingival health in institutionalized and non-institutionalized subjects with Down’s syndrome. J Intellect Disabil Res 2003; 47 (Pt 2) 101-107
    CrossrefPubMedGoogle Scholar
  • 22 Fornieles G, Rosety MA, Elosegui S. et al. Salivary testosterone and immunoglobulin A were increased by resistance training in adults with Down syndrome. Braz J Med Biol Res 2014; 47 (04) 345-348
    CrossrefPubMedGoogle Scholar
  • 23 Chaushu S, Yefenof E, Becker A, Shapira J, Chaushu G. Severe impairment of secretory Ig production in parotid saliva of Down syndrome individuals. J Dent Res 2002; 81 (05) 308-312
    CrossrefPubMedGoogle Scholar
  • 24 Chaushu S, Chaushu G, Zigmond M. et al. Age-dependent deficiency in saliva and salivary antibodies secretion in Down’s syndrome. Arch Oral Biol 2007; 52 (11) 1088-1096
    CrossrefPubMedGoogle Scholar
  • 25 Balaji K, Milne TJ, Drummond BK, Cullinan MP, Coates DE. A comparison of salivary IgA in children with Down syndrome and their family members. Arch Oral Biol 2016; 67: 39-45
    CrossrefPubMedGoogle Scholar
  • 26 Wells GA, Shea B, O’Connell D, et al. NewCastle–Ottawa Quality Assessment Scale—Case Control Studies. Namibia: Belia Vida Centre; 2017
  • 27 Nogueira RD, Alves AC, Napimoga MH, Smith DJ, Mattos-Graner RO. Characterization of salivary immunoglobulin A responses in children heavily exposed to the oral bacterium Streptococcus mutans: influence of specific antigen recognition in infection. Infect Immun 2005; 73 (09) 5675-5684
    CrossrefPubMedGoogle Scholar
  • 28 Gregory RL, Michalek SM, Filler SJ, Mestecky J, McGhee JR. Prevention of Streptococcus mutans colonization by salivary IgA antibodies. J Clin Immunol. 1985;5(1):55-62. Doi:10.1007/BF00915169
  • 29 Takeuchi H, Kanehisa J, Hori Y. et al. Periodontal disease and resistance factor. III. Localization of secretory IgA and serum IgA in the inflamed human gingiva. Nihon Shishubyo Gakkai Kaishi 1982; 24 (03) 416-420
    CrossrefPubMedGoogle Scholar
  • 30 Hajishengallis G, Nikolova E, Russell MW. Inhibition of Streptococcus mutans adherence to saliva-coated hydroxyapatite by human secretory immunoglobulin A (S-IgA) antibodies to cell surface protein antigen I/II: reversal by IgAl protease cleavage. Infect Immun 1992; 60 (12) 5057-5064
    CrossrefPubMedGoogle Scholar
  • 31 Orner G. Dental caries experience among children with Down’s syndrome and their sibs. Arch Oral Biol 1975; 20 (10) 627-634
    CrossrefPubMedGoogle Scholar
  • 32 Jalil RA, Ashley FP, Wilson RF. The relationship between 48-h dental plaque accumulation in young human adults and the concentrations of hypothiocyanite, 'free' and 'total' lysozyme, lactoferrin and secretory immunoglobulin A in saliva. Arch Oral Biol 1992;37(1):23-28. Doi:10.1016/0003-9969(92)90148-2
  • 33 Gregory RL, Michalek SM, Filler SJ, Mestecky J, McGhee JR. Prevention of Streptococcus mutans colonization by salivary IgA antibodies. J Clin Immunol 1985; 5 (01) 55-62
    CrossrefPubMedGoogle Scholar